Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Work In Process: 2016-2025

Historic Work In Process for Collegium Pharmaceutical (COLL) over the last 9 years, with Sep 2025 value amounting to $11.6 million.

  • Collegium Pharmaceutical's Work In Process fell 33.12% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 million, marking a year-over-year decrease of 33.12%. This contributed to the annual value of $13.2 million for FY2024, which is 95.30% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Work In Process of $11.6 million as of Q3 2025, which was down 3.56% from $12.1 million recorded in Q2 2025.
  • Collegium Pharmaceutical's Work In Process' 5-year high stood at $46.4 million during Q2 2022, with a 5-year trough of $802,000 in Q1 2021.
  • For the 3-year period, Collegium Pharmaceutical's Work In Process averaged around $10.7 million, with its median value being $11.6 million (2025).
  • As far as peak fluctuations go, Collegium Pharmaceutical's Work In Process spiked by 4,252.49% in 2022, and later plummeted by 83.92% in 2023.
  • Quarterly analysis of 5 years shows Collegium Pharmaceutical's Work In Process stood at $1.0 million in 2021, then soared by 2,350.05% to $24.7 million in 2022, then plummeted by 72.68% to $6.7 million in 2023, then surged by 95.30% to $13.2 million in 2024, then tumbled by 33.12% to $11.6 million in 2025.
  • Its Work In Process was $11.6 million in Q3 2025, compared to $12.1 million in Q2 2025 and $11.6 million in Q1 2025.